|
|
|
|
|
Detail |
| hsa-miR-200c |
|
Unspecified |
MicroRNA signatures in human ovarian cancer. |
2007 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
High-throughput microRNAome analysis in human germ cell tumours. |
2007 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Prognostic Values of microRNAs in Colorectal Cancer. |
2006 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and drug-resistant phenotypes in human breast cancer cells. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: Evidence supporting a mesothelial-to-epithelial transition |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
MicroRNA expression profiles in serous ovarian carcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients. |
2008 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Unspecified |
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. |
2009 |
|
|
|
|
|
|
| hsa-miR-200c |
|
Causal |
Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression |
2009 |
|
|
|
|
|
|